FMO5 and Parkinson disease: Taken together, our study highlights that proper modulation of NADPH oxidase and its downstream pathways might hold a potential therapeutic aspect for the treatment of Parkinson’s disease as well as other neurodegenerative diseases associated with increased oxidative stress and accumulation of toxic cellular constituents.